HJ Research delivers in-depth insights on the global Hereditary Cancer Testing market in its upcoming report titled, Global Hereditary Cancer Testing Market Report 2018-2029. According to this study, the global Hereditary Cancer Testing market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Hereditary Cancer Testing market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Hereditary Cancer Testing market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Hereditary Cancer Testing industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Hereditary Cancer Testing industry.
Global Hereditary Cancer Testing market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Hereditary Cancer Testing industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Hereditary Cancer Testing market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Hereditary Cancer Testing. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Hereditary Cancer Testing market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Hereditary Cancer Testing in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Hereditary Cancer Testing market include:
Myriad Genetics
Myogenes
Laboratory Corporation of America
Biocartis
Quest Diagnostics
Pathway Genomics
Invitae Corporation
Strand Life Sciences
Market segmentation, by product types:
Biopsy
Imaging
Others
Market segmentation, by applications:
Hospital
Clinics
Diagnostic Centers
1 Industry Overview of Hereditary Cancer Testing
1.1 Research Scope
1.2 Market Segmentation by Types of Hereditary Cancer Testing
1.3 Market Segmentation by End Users of Hereditary Cancer Testing
1.4 Market Dynamics Analysis of Hereditary Cancer Testing
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Hereditary Cancer Testing Industry
2.1 Myriad Genetics
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Hereditary Cancer Testing Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Myogenes
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Hereditary Cancer Testing Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Laboratory Corporation of America
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Hereditary Cancer Testing Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Biocartis
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Hereditary Cancer Testing Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Quest Diagnostics
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Hereditary Cancer Testing Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Pathway Genomics
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Hereditary Cancer Testing Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Invitae Corporation
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Hereditary Cancer Testing Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Strand Life Sciences
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Hereditary Cancer Testing Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
3 Global Hereditary Cancer Testing Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Hereditary Cancer Testing by Regions (2018-2023)
3.2 Global Sales Revenue of Hereditary Cancer Testing by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Hereditary Cancer Testing by Types (2018-2023)
3.4 Global Sales Revenue of Hereditary Cancer Testing by End Users (2018-2023)
4 Northern America Hereditary Cancer Testing Market Analysis by Countries, Types and End Users
4.1 Northern America Hereditary Cancer Testing Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Hereditary Cancer Testing Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Hereditary Cancer Testing Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
4.5 Canada Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
5 Europe Hereditary Cancer Testing Market Analysis by Countries, Types and End Users
5.1 Europe Hereditary Cancer Testing Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Hereditary Cancer Testing Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Hereditary Cancer Testing Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
5.5 France Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
5.6 UK Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
5.7 Italy Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
5.8 Russia Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
5.9 Spain Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
5.10 Netherlands Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
6 Asia Pacific Hereditary Cancer Testing Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Hereditary Cancer Testing Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Hereditary Cancer Testing Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Hereditary Cancer Testing Sales Revenue Analysis by End Users (2018-2023)
6.4 China Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
6.5 Japan Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
6.6 Korea Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
6.7 India Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
6.8 Australia Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
6.9 Indonesia Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
6.10 Vietnam Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
7 Latin America Hereditary Cancer Testing Market Analysis by Countries, Types and End Users
7.1 Latin America Hereditary Cancer Testing Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Hereditary Cancer Testing Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Hereditary Cancer Testing Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
7.5 Mexico Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
7.6 Argentina Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
7.7 Colombia Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Hereditary Cancer Testing Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Hereditary Cancer Testing Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Hereditary Cancer Testing Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Hereditary Cancer Testing Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
8.6 South Africa Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
8.7 Egypt Hereditary Cancer Testing Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Hereditary Cancer Testing Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Hereditary Cancer Testing by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Hereditary Cancer Testing by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Hereditary Cancer Testing by End Users (2024-2029)
10.4 Global Revenue Forecast of Hereditary Cancer Testing by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Hereditary Cancer Testing
11.1 Upstream Analysis of Hereditary Cancer Testing
11.2 Downstream Major Consumers Analysis of Hereditary Cancer Testing
11.3 Major Suppliers of Hereditary Cancer Testing with Contact Information
11.4 Supply Chain Relationship Analysis of Hereditary Cancer Testing
12 Hereditary Cancer Testing New Project Investment Feasibility Analysis
12.1 Hereditary Cancer Testing New Project SWOT Analysis
12.2 Hereditary Cancer Testing New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Hereditary Cancer Testing Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Hereditary Cancer Testing
Table End Users of Hereditary Cancer Testing
Figure Market Drivers Analysis of Hereditary Cancer Testing
Figure Market Challenges Analysis of Hereditary Cancer Testing
Figure Market Opportunities Analysis of Hereditary Cancer Testing
Table Market Drivers Analysis of Hereditary Cancer Testing
Table Myriad Genetics Information List
Figure Hereditary Cancer Testing Specifications of Myriad Genetics
Table Hereditary Cancer Testing Revenue (Million USD) and Gross Margin of Myriad Genetics (2018-2023)
Figure Hereditary Cancer Testing Revenue (Million USD) and Global Market Share of Myriad Genetics (2018-2023)
Table Myogenes Information List
Figure Hereditary Cancer Testing Specifications of Myogenes
Table Hereditary Cancer Testing Revenue (Million USD) and Gross Margin of Myogenes (2018-2023)
Figure Hereditary Cancer Testing Revenue (Million USD) and Global Market Share of Myogenes (2018-2023)
Table Laboratory Corporation of America Information List
Figure Hereditary Cancer Testing Specifications of Laboratory Corporation of America
Table Hereditary Cancer Testing Revenue (Million USD) and Gross Margin of Laboratory Corporation of America (2018-2023)
Figure Hereditary Cancer Testing Revenue (Million USD) and Global Market Share of Laboratory Corporation of America (2018-2023)
Table Biocartis Information List
Figure Hereditary Cancer Testing Specifications of Biocartis
Table Hereditary Cancer Testing Revenue (Million USD) and Gross Margin of Biocartis (2018-2023)
Figure Hereditary Cancer Testing Revenue (Million USD) and Global Market Share of Biocartis (2018-2023)
Table Quest Diagnostics Information List
Figure Hereditary Cancer Testing Specifications of Quest Diagnostics
Table Hereditary Cancer Testing Revenue (Million USD) and Gross Margin of Quest Diagnostics (2018-2023)
Figure Hereditary Cancer Testing Revenue (Million USD) and Global Market Share of Quest Diagnostics (2018-2023)
Table Pathway Genomics Information List
Figure Hereditary Cancer Testing Specifications of Pathway Genomics
Table Hereditary Cancer Testing Revenue (Million USD) and Gross Margin of Pathway Genomics (2018-2023)
Figure Hereditary Cancer Testing Revenue (Million USD) and Global Market Share of Pathway Genomics (2018-2023)
Table Invitae Corporation Information List
Figure Hereditary Cancer Testing Specifications of Invitae Corporation
Table Hereditary Cancer Testing Revenue (Million USD) and Gross Margin of Invitae Corporation (2018-2023)
Figure Hereditary Cancer Testing Revenue (Million USD) and Global Market Share of Invitae Corporation (2018-2023)
Table Strand Life Sciences Information List
Figure Hereditary Cancer Testing Specifications of Strand Life Sciences
Table Hereditary Cancer Testing Revenue (Million USD) and Gross Margin of Strand Life Sciences (2018-2023)
Figure Hereditary Cancer Testing Revenue (Million USD) and Global Market Share of Strand Life Sciences (2018-2023)
Table Global Revenue (Million USD) of Hereditary Cancer Testing by Regions (2018-2023)
Table Global Revenue (Million USD) of Hereditary Cancer Testing by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Hereditary Cancer Testing by Types (2018-2023)
Table Global Revenue (Million USD) of Hereditary Cancer Testing by End Users (2018-2023)
Table Northern America Hereditary Cancer Testing Revenue (Million USD) by Countries (2018-2023)
Table Northern America Hereditary Cancer Testing Revenue (Million USD) by Types (2018-2023)
Table Northern America Hereditary Cancer Testing Revenue (Million USD) by End Users (2018-2023)
Figure United States Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Hereditary Cancer Testing Revenue (Million USD) by Countries (2018-2023)
Table Europe Hereditary Cancer Testing Revenue (Million USD) by Types (2018-2023)
Table Europe Hereditary Cancer Testing Revenue (Million USD) by End Users (2018-2023)
Figure Germany Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Hereditary Cancer Testing Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Hereditary Cancer Testing Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Hereditary Cancer Testing Revenue (Million USD) by End Users (2018-2023)
Figure China Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Hereditary Cancer Testing Revenue (Million USD) by Countries (2018-2023)
Table Latin America Hereditary Cancer Testing Revenue (Million USD) by Types (2018-2023)
Table Latin America Hereditary Cancer Testing Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Hereditary Cancer Testing Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Hereditary Cancer Testing Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Hereditary Cancer Testing Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Hereditary Cancer Testing by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Hereditary Cancer Testing by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Hereditary Cancer Testing by End Users (2024-2029)
Table Major Consumers with Contact Information of Hereditary Cancer Testing
Table Major Suppliers of Hereditary Cancer Testing with Contact Information
Figure Supply Chain Relationship Analysis of Hereditary Cancer Testing
Table New Project SWOT Analysis of Hereditary Cancer Testing
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Hereditary Cancer Testing
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Hereditary Cancer Testing Industry
Table Part of References List of Hereditary Cancer Testing Industry
Table Units of Measurement List
Table Part of Author Details List of Hereditary Cancer Testing Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Hereditary Cancer Testing industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Hereditary Cancer Testing market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Hereditary Cancer Testing manufacturers, Hereditary Cancer Testing raw material suppliers, Hereditary Cancer Testing distributors as well as buyers. The primary sources from the supply side include Hereditary Cancer Testing manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Hereditary Cancer Testing raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Hereditary Cancer Testing industry landscape and trends, Hereditary Cancer Testing market dynamics and key issues, Hereditary Cancer Testing technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Hereditary Cancer Testing competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Hereditary Cancer Testing market size and forecast by regions, Hereditary Cancer Testing market size and forecast by application, Hereditary Cancer Testing market size and forecast by types, Hereditary Cancer Testing company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
